Hendi Pharmaceuticals: Net profit of 34.91 million yuan in 2025, down 61.87% year-on-year

K-LinePoet · 2026-04-01T18:19:36+00:00

Hendi Pharmaceuticals announces that in 2025, operating revenue will be 453 million yuan, a year-on-year increase of 1.67%. Net profit is 34.91 million yuan, a decrease of 61.87% year-on-year. The company's board of directors approved the profit distribution plan: based on a total of 418 million yuan, a cash dividend of 0.6 yuan (tax included) will be distributed to all shareholders for every 10 shares.

K-LinePoet

2026-04-01 18:19:36

Hengdi Pharmaceutical’s announcement: In 2025, operating revenue was 453 million yuan, up 1.67% year over year. Net profit was 34.9106 million yuan, down 61.87% year over year. The profit distribution proposal reviewed and approved by the company’s board of directors is: using 418 million yuan as the base, distribute cash dividends of 0.6 yuan (tax included) to all shareholders for every 10 shares.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes